Usiskin, Keith <br/><br/>
Safety and tolerability of canagliflozin in patients with type 2 diabetes mellitus: pooled analysis of phase 3 study results.  [electronic resource] 

 -  Postgraduate medicine  May 2014 
 - 16-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1941-9260 
<br/><br/><label>Standard No.: </label>10.3810/pgm.2014.05.2753  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Canagliflozin<br/>Clinical Trials, Phase III as Topic<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Dose-Response Relationship, Drug<br/>Drug Therapy, Combination<br/>Female<br/>Glucosides--administration & dosage<br/>Humans<br/>Hypoglycemia--chemically induced<br/>Hypoglycemic Agents--administration & dosage<br/>Incidence<br/>Kidney Function Tests<br/>Lipids--blood<br/>Male<br/>Middle Aged<br/>Randomized Controlled Trials as Topic<br/>Severity of Illness Index<br/>Sex Factors<br/>Sodium-Glucose Transporter 2 Inhibitors<br/>Thiophenes--administration & dosage